Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands.

Autor: Hinsenveld FJ; Department of Urology, Amsterdam University Medical Centres location Vrije University Medical Centre, Amsterdam, The Netherlands., Boormans JL; Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands. Electronic address: j.boormans@erasmusmc.nl., van der Poel HG; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Schoot DKE; Department of Urology, Amphia Hospital, Breda, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centres location Vrije University Medical Centre, Amsterdam, The Netherlands., Aben KKH; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands., Arends TJ; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Ausems PJ; Department of Urology, HagaZiekenuis, Den Haag, The Netherlands., Baselmans D; Department of Urology, Máxima Medical Centre, Veldhoven, The Netherlands., Berger C; Department of Urology, Haaglanden Medical Centre, Den Haag, The Netherlands., Berrens A; Department of Urology, Franciscus Hospital, Rotterdam, The Netherlands., Bickerstaffe H; Department of Urology, Bravis Hospital, Bergen op Zoom, Roosendaal, The Netherlands., Bos SD; Department of Urology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., Braam M; Department of Urology, Martini Hospital, Groningen, The Netherlands., Buddingh KT; Department of Urology, HagaZiekenuis, Den Haag, The Netherlands., Claus S; Department of Urology, Catharina Hospital, Eindhoven, The Netherlands., Dekker K; Department of Urology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., van Doeveren T; Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands., Einerhand S; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Fossion L; Department of Urology, Máxima Medical Centre, Veldhoven, The Netherlands., van Gennep EJ; Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands., van Ginkel N; Department of Urology, Spaarne Gasthuis, Haarlem, Hoofddorp, The Netherlands., Palacios G; Department of Urology, Haaglanden Medical Centre, Den Haag, The Netherlands., Hermans T; Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands., Hobijn MM; Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands., van Huystee SH; Department of Urology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., Jaspers-Valentijn M; Department of Urology, Bravis Hospital, Bergen op Zoom, Roosendaal, The Netherlands., Klaver OS; Department of Urology, Maasstad Hospital, Rotterdam, The Netherlands., Koldewijn EL; Department of Urology, Catharina Hospital, Eindhoven, The Netherlands., Korsten L; Department of Urology, Elisabeth TweeSteden Hospital, Tilburg, The Netherland., Lenting A; Department of Urology, Franciscus Hospital, Rotterdam, The Netherlands., Lentjes KJ; Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands., Luiting HB; Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands., van der Meer S; Department of Urology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centres location Vrije University Medical Centre, Amsterdam, The Netherlands., Noordzij MA; Department of Urology, Spaarne Gasthuis, Haarlem, Hoofddorp, The Netherlands., Nooter RI; Department of Urology, Franciscus Hospital, Rotterdam, The Netherlands., Notenboom C; Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands., Oomen R; Department of Urology, Elisabeth TweeSteden Hospital, Tilburg, The Netherland., van Roermund J; Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands., de Rooij J; Department of Urology, Máxima Medical Centre, Veldhoven, The Netherlands., Roshani H; Department of Urology, HagaZiekenuis, Den Haag, The Netherlands., Schrier BP; Department of Urology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., van der Slot MA; Department of Urology, Maasstad Hospital, Rotterdam, The Netherlands., Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Stelwagen PJ; Department of Urology, Amsterdam University Medical Centres location Vrije University Medical Centre, Amsterdam, The Netherlands., Stroux A; Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands., van der West A; Department of Urology, Spaarne Gasthuis, Haarlem, Hoofddorp, The Netherlands., Wijsman BP; Department of Urology, Elisabeth TweeSteden Hospital, Tilburg, The Netherland., Windt W; Department of Urology, Martini Hospital, Groningen, The Netherlands., van Zanten P; Department of Urology, HagaZiekenuis, Den Haag, The Netherlands., van Beek SC; Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands.

Publikováno v: Urologic oncology [Urol Oncol] 2022 Feb; Vol. 40 (2), pp. 60.e1-60.e9. Date of Electronic Publication: 2021 Jul 22.

Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study.

Autor: Rijksen BLT; Department of Radiotherapy, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: b.rijksen@nki.nl., Pos FJ; Department of Radiotherapy, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands., Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Center, Amsterdam, The Netherlands., Vernooij RWM; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Jansen H; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., van Andel G; Department of Urology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Wijsman BP; Department of Urology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Busstra MB; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Kaa CAH; Department of Pathology, Laboratory for Pathology East Netherlands, Hengelo, The Netherlands., van Leenders GJLH; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Hamberg P; Department of Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., van den Berkmortel F; Department of Oncology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Fütterer JJ; Department of Radiology, Radboud University Medical Center, Nijmegen, The Netherlands., Kiemeney LA; Department of Epidemiology, Radboud University Medical Center, Nijmegen, The Netherlands., van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Aben KKH; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.

Publikováno v: European urology focus [Eur Urol Focus] 2021 Mar; Vol. 7 (2), pp. 332-339. Date of Electronic Publication: 2019 Nov 17.

Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors.

Autor: Jansen H; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. hannekejansen@gmail.com., van Oort IM; Department of Urology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., van Andel G; Department of Urology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Wijsman BP; Department of Urology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Pos FJ; Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hulshof MCCM; Department of Radiotherapy, Academic Medical Center, Amsterdam, The Netherlands., Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., van Leenders GJLH; Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands., Fütterer JJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., Busstra MB; Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands., van Moorselaar RJA; Department of Urology, VU University Medical Center, Amsterdam, The Netherlands., Kiemeney LA; Department of Urology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.; Department for Health Evidence, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Aben KKH; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Department for Health Evidence, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2019 May; Vol. 22 (2), pp. 337-343. Date of Electronic Publication: 2018 Nov 14.

Cancer survivors' preference for follow-up care providers: a cross-sectional study from the population-based PROFILES-registry.

Autor: Huibertse LJ; a Department of Research , Netherlands Comprehensive Cancer Organization , Utrecht , The Netherlands., van Eenbergen M; a Department of Research , Netherlands Comprehensive Cancer Organization , Utrecht , The Netherlands., de Rooij BH; a Department of Research , Netherlands Comprehensive Cancer Organization , Utrecht , The Netherlands.; b CoRPS - Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology , Tilburg University , Tilburg , The Netherlands., Bastiaens MT; c Department of Dermatology , Elisabeth-TweeSteden Hospital , Tilburg , The Netherlands., Fossion LM; d Department of Urology , Maxima Medical Center , Eindhoven , The Netherlands., de la Fuente RB; e Department of Urology , Elkerliek Hospital , Helmond , The Netherlands., Kil PJ; f Department of Urology , Elisabeth-TweeSteden Hospital , Tilburg , The Netherlands., Koldewijn EL; g Department of Urology , Catharina Hospital , Eindhoven , The Netherlands., Meier AH; h Department of Urology , VieCuri Hospital , Venlo , The Netherlands., Mommers RJ; i Department of Dermatology , St Anna Hospital , Geldrop , The Netherlands., Niemer AQ; j Department of Urology , Bernhoven Hospital , Uden , The Netherlands., Oddens JR; k Department of Urology , Jeroen Bosch Hospital , Den Bosch , The Netherlands., Oomens EH; l Department of Urology , Amphia Hospital , Breda , The Netherlands., Prins M; m Department of Dermatology , Maxima Medical Center , Eindhoven , The Netherlands., de Roos KP; n DermaPark , Uden , The Netherlands., Thissen MR; o Department of Dermatology , Maastricht University Medical Center , Maastricht , The Netherlands.; p Department of Dermatology , Catharina Hospital , Eindhoven , The Netherlands., Timmermans MW; q Department of Dermatology , Bernhoven Hospital , Uden , The Netherlands., Wijsman BP; f Department of Urology , Elisabeth-TweeSteden Hospital , Tilburg , The Netherlands., van de Poll-Franse LV; a Department of Research , Netherlands Comprehensive Cancer Organization , Utrecht , The Netherlands.; b CoRPS - Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology , Tilburg University , Tilburg , The Netherlands.; r Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , The Netherlands., Ezendam NP; a Department of Research , Netherlands Comprehensive Cancer Organization , Utrecht , The Netherlands.; b CoRPS - Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology , Tilburg University , Tilburg , The Netherlands.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2017 Feb; Vol. 56 (2), pp. 278-287. Date of Electronic Publication: 2017 Jan 09.